BABA vs IBP

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

IBP presents a dichotomy of elite operational efficiency and concerning valuation/insider signals. While the Piotroski F-Score of 4/9 indicates stable health and the company boasts a superior ROE of 37.51% compared to its sector, the stock trades at a massive premium to its Graham Number ($76.02). Earnings growth remains strong (18.20% YoY) despite stagnant revenue growth (-0.40%), suggesting internal cost optimizations rather than market expansion. The primary headwind is a starkly bearish insider sentiment, highlighted by the CEO selling 400,000 shares.